Sickle Cell Disease (SCD) Burden on Patients Treated With Hydroxyurea (HU): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)

被引：0
|
作者：
Ezzat, Hatoon M. [1 ]
Al Zayed, Abdullah Hasan [2 ]
Al Saeed, Hussain H. [2 ]
Al Darwish, Mohamed [2 ]
Albagshi, Muneer [3 ]
Malhan, Hafiz [4 ]
Tarawah, Ahmad [5 ]
Al Manea, Aljawhara [6 ]
Alhazmi, Iman [6 ]
Qari, Mohamed [7 ]
Alzahrani, Azzah [8 ]
Alzahrani, Mohsen [9 ]
Soliman, Wesam [10 ]
Askar, Farid [10 ]
Yassin, Al Shaimaa [10 ]
Jastaniah, Wasil [11 ]
机构：
[1] Johns Hopkins Aramco Healthcare, MOH, Dhahran, Saudi Arabia
[2] Qatif Cent Hosp, Qatif, Saudi Arabia
[3] Almana Gen Hosp Al Ahsa, Hofouf, Saudi Arabia
[4] Prince Mohamed Bin Naser, Jizan, Saudi Arabia
[5] King Salman Med City Al Madinah, Madinah, Saudi Arabia
[6] King Fahad Armed Forces Hosp, Jeddah, Saudi Arabia
[7] King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia
[8] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[9] King Abdul Aziz Med City, Riyadh, Saudi Arabia
[10] Novartis Saudi Ltd, Riyadh, Saudi Arabia
[11] King Faisal Specialist Hosp & Res Ctr Gen Org, Jeddah, Saudi Arabia
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166723
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
904
引用
收藏
页码：10879 / 10880
页数：2
相关论文
共 50 条
  • [1] Evidence Gaps in the Management of Patients with Sickle Cell Disease (SCD) by Non-specialist Healthcare Professionals (HCPs): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)
    Jastaniah, Wasil
    Al Zayed, Abdullah Hasan
    Al Saeed, Hussain H.
    Al Darwish, Mohamed
    Albagshi, Muneer
    Malhan, Hafiz
    Tarawah, Ahmad
    Al Manea, Aljawhara
    Alhazmi, Iman
    Qari, Mohamed
    Alzahrani, Azzah
    Alzahrani, Mohsen
    Soliman, Wesam
    Askar, Farid
    Almustafa, Sukina
    Ezzat, Hatoon M.
    BLOOD, 2022, 140 : 5133 - 5134
  • [2] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
    Motwani, J
    Lawson, SE
    Darbyshire, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25
  • [3] Severity and burden of sickle cell disease (SCD) in France: A nationwide real-world study
    Brousse, Valentine
    Bernaudin, Francoise
    Dheyriat, Lucile
    Chillotti, Louis
    Goguillot, Melanie
    Gallagher, Meghan
    Bugnard, Francoise
    Benard, Steve
    Habibi, Anoosha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 415 - 416
  • [4] Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?
    Galacteros, Frederic
    Voskaridou, Ersi
    Habibi, Anoosha
    Cannas, Giovanna
    Joseph, Laure
    Loko, Gylna
    De Montalembert, Mariane
    Elenga, Narcisse
    Benkerrou, Malika
    BLOOD, 2020, 136
  • [5] Stroke Risk In Children with Sickle Cell Disease (SCD) Treated by Hydroxyurea (HU). A Belgian Center Experience
    Lefevre, Nicolas
    Dufour, Dominique
    Gulbis, Beatrice
    Le, Phu-Quoc
    Heijmans, Catherine
    Devalck, Christine
    Huybrechts, Sophie
    Ferster, Alina
    BLOOD, 2010, 116 (21) : 1091 - 1091
  • [6] Hydroxyurea (HU) therapy improves cognitive functioning in sickle cell disease (SCD) patients.
    Bernaudin, F
    Freard, F
    Lesprit, E
    Roudot-Thoraval, F
    Verlhac, S
    Benkerrou, M
    Thuret, I
    Mardini, R
    Vannier, JP
    Ploix, E
    Romero, M
    Casse-Perrot, C
    Helly, M
    Gillard, E
    Brugieres, P
    Reinert, P
    BLOOD, 1999, 94 (10) : 416A - 417A
  • [7] Documenting the effectiveness of hydroxyurea (HU) to treat sickle cell disease (SCD) in the community setting
    Lanzkron, Sophie
    Haywood, Carlton, Jr.
    Fagan, Peter
    BLOOD, 2007, 110 (11) : 291A - 291A
  • [8] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    PEDIATRIC RESEARCH, 2003, 53 (04) : 293A - 294A
  • [9] Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution
    Di Maggio, Rosario
    Hsieh, Matthew
    Fitzhugh, Courtney
    Zhao, Xiongce
    Calvaruso, Giusi
    Rigano, Paolo
    Renda, Disma
    Siragusa, Sergio
    Tisdale, John F.
    Maggio, Aurelio
    BLOOD, 2014, 124 (21)
  • [10] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    BLOOD, 2002, 100 (11) : 28B - 28B
12345